Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses

Vaccine

Volumn 6, Issue 6, 1988, Pages 533-539

  Fekadu, M ^a   Shaddock, J H ^a   Sanderlin, D W ^a   Smith, J S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

bats; Duvenhage virus; rabies

Indexed keywords

DIPLOID CELL VACCINE; MONOCLONAL ANTIBODY; POLIOMYELITIS VACCINE; RABIES VACCINE;

ANIMAL EXPERIMENT; DOG; DUVENHAGE VIRUS; MOUSE; NONHUMAN; PROTECTION; RABIES; RABIES VIRUS;

ANIMAL; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; CHIROPTERA; DOGS; IMMUNIZATION; MICE; RABIES VACCINES; RABIES VIRUS; RHABDOVIRIDAE;

EID: 0024212083     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(88)90107-7     Document Type: Article

References (39)

1. Measures applied in Denmark to control the rabies epizootics in 1977-80
2. Bat rabies in Denmark
3. Bat rabies in Denmark
4. Bat rabies-Europe
5. Antigenic variants of rabies virus
6. An unusual case of human rabies thought to be of Chiropteran origin
7. Application of monoclonal antibodies for epidemiological investigation and oral vaccine studies
8. Connaissances actuelles sur les propriétés et le pouvoir vaccinant de la glycoproteine rabique
9. Rabies related viruses
10. Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies
11. Cross-reactivity and cross-protection: rabies virus variants and rabies-related viruses
12. A plaque-purified rabies virus (strain V-319) derived from a vampire bat (Desmodus rotundus) in Mexico: vaccine potential
13. Human rabies-Kenya
14. Human rabies of bat origin in Europe
15. Monoclonal antibody studies of rabies in insectivorous bats of the United States
16. Antigenic characteristics of isolates associated with a new epizootic of raccoon rabies in the USA
17. Enzyme immunoassay for rabies antibody in hybridoma fluids and its application to differentiation of street and laboratory strains of rabies virus
18. Monoclonal antibodies against rabies virus produced by somatic cell hybridization: Detection of antigenic variants
19. A rapid tissue culture test for determining rabies-neutralizing antibody
20. Inactivation of rabies virus in reagents used for the fluorescent rabies antibody test
21. The NIH test for potency
22. Modified Habel test for potency
23. Methods of calculation
24. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene
25. Transcription and replication of rhabdoviruses
26. Antigenic properties of rabies virus components
27. Experimental rabies in cats: immune response and persistence of immunity
28. Epidemiologic analysis of antigenic variations of street rabies virus: detection by monoclonal antibodies
29. Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies related virus proteins
30. Demonstration of antigenic variation among rabies virus isolates by using monoclonal antibodies to nucleocapsid proteins
31. Vaccination and challenge of mice with viruses or the rabies serogroup
32. Experimental infection of dogs and monkeys with two rabies serogroup viruses, Lagos bat and Mokola (Iban 27–377)
33. Mokola virus infection in cats and a dog in Zimbabwe
34. Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody
35. Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein
36. Human rabies vaccines induce neutralizing antibodies against the European bat virus (Duvenhage)
37. Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies